Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. bioinformatics platform
Show results for
Products
Services
Software

Companies

News
Articles
Downloads

Refine by
Date

  • Older

Bioinformatics Platform Articles & Analysis: Older

17 news found

Simplify Your Microbiome Research with MicrobioSeq’s Microbial Biomarker Discovery Service

Simplify Your Microbiome Research with MicrobioSeq’s Microbial Biomarker Discovery Service

The Microbial Biomarker Discovery service uses CD Genomics’ proprietary MicrobioSeq platform, which combines next-generation sequencing with advanced bioinformatics tools. This platform has been optimized to analyze complex microbiome samples, including those from human, animal, plant, and environmental sources. ...

ByCD Genomics


CRISPR Off-Target Analysis Now Available with CD Genomics’ Bioinformatics-Analysis Platform

CRISPR Off-Target Analysis Now Available with CD Genomics’ Bioinformatics-Analysis Platform

The Bioinformatics-Analysis is a subdivision of CD Genomics, providing reliable next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction services, and other related data analysis services. ...

ByCD Genomics


Profacgen Updated Its In Silico Protein-protein Interactions Prediction Service

Profacgen Updated Its In Silico Protein-protein Interactions Prediction Service

Profacgen, a biotechnology company that offers bioinformatics platform to help academic and industrial researchers to explore, understand and analyze complex biological data in various biotechnological programs and projects, recently updated its in silico protein-protein interactions prediction service to meet diversified needs of its customers. ...

ByProfacgen


Metatranscriptome Analysis Service Is Now Available at CD Genomics

Metatranscriptome Analysis Service Is Now Available at CD Genomics

CD Genomics provides metatranscriptome sequencing data analysis service using bioinformatics analysis platform, which can comprehensively analyze the dynamic changes of microbial flora. ...

ByCD Genomics


Pronalyse Launches Antibody Drug Conjugates (ADCs) Characterization Service for Drug Discovery

Pronalyse Launches Antibody Drug Conjugates (ADCs) Characterization Service for Drug Discovery

Creative Proteomics Pronalyse’s bioinformatics platform will help you solve these problems and challenges,” said the Senior Scientist of Creative Proteomics. ...

ByCreative Proteomics


Microarray Data Analysis Service Now Available by CD Genomics's Bioinformatics-Analysis Platform

Microarray Data Analysis Service Now Available by CD Genomics's Bioinformatics-Analysis Platform

For example, through gene microarrays, genes that may be affected by diseases can be discovered in a short time as biomarkers for early diagnosis. "The platform has a skilled bioinformatics analysis team with extensive experience in biological data analysis projects. ...

ByCD Genomics


CD Genomics: The Biomedical Bioinformatics Platform Unveils Biomarker and Target Discovery Data Analysis Service

CD Genomics: The Biomedical Bioinformatics Platform Unveils Biomarker and Target Discovery Data Analysis Service

The Biomedical Bioinformatics Platform belongs to CD Genomics and has a good reputation for assisting researchers with data analysis challenges, including NGS data processing, analysis, interpretation, and general genomic data analysis, as well as data mining, statistical modeling, data integration, information science, database construction, and management. ...

ByCD Genomics


Epigenetics Data Analysis Service Now Available by CD Genomics’s Bioinformatics-Analysis Platform

Epigenetics Data Analysis Service Now Available by CD Genomics’s Bioinformatics-Analysis Platform

Bioinformatics-analysis Platform belongs to CD Genomics, which provides reliable next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction, and other related data analysis business. ...

ByCD Genomics


CD Genomics: Targeted Proteomics Analysis Service Now Available by Bioinformatics-Analysis Platform

CD Genomics: Targeted Proteomics Analysis Service Now Available by Bioinformatics-Analysis Platform

Bioinformatics-analysis Platform belongs to CD Genomics, which provides reliable next-generation and third-generation high-throughput sequencing data analysis, comprehensive technology services, database construction, and other related data analysis business. ...

ByCD Genomics


GeneCentric Therapeutics Closes $7.5 Million Series B1 Financing

GeneCentric Therapeutics Closes $7.5 Million Series B1 Financing

” In addition to developing its signature and diagnostic pipeline, GeneCentric will continue to pursue key pharmaceutical and biotechnology collaborations where its core technologies can be used to advance new and ongoing partner programs. About the rT(I)ME Explorer Platform GeneCentric’s broad pipeline of novel predictive response signatures has been built over ...

ByGeneCentric Therapeutics, Inc.


Profacgen Enables Custom Bioinformatics Software Development for Researchers Worldwide

Profacgen Enables Custom Bioinformatics Software Development for Researchers Worldwide

Bioinformatics focuses on developing methods and software tools for understanding biological data using mathematical and statistical techniques. ...

ByProfacgen


CD ComputaBio Launches the In Silico PPI Prediction Service to Aid in Drug Action Mechanism Research

CD ComputaBio Launches the In Silico PPI Prediction Service to Aid in Drug Action Mechanism Research

“As one of the trusted service providers in the field of biotechnology, CD ComputaBio’s analysis services utilize advanced bioinformatics analysis platforms and mature expertise to help customers meet their project needs. ...

ByCD ComputaBio


DermBiont Announces Positive Results in Phase 2a Clinical Trial in Atopic Dermatitis with a Topical Live Biotherapeutic

DermBiont Announces Positive Results in Phase 2a Clinical Trial in Atopic Dermatitis with a Topical Live Biotherapeutic

DermBiont's biotherapeutics discovery team leverages computational biology and a proprietary bioinformatics platform to identify clinically meaningful dysbiosis related to common skin diseases and mines a curated library of microbes to build a pipeline of products to treat identified dysbiosis across indications. ...

ByDermBiont, Inc.


DermBiont Announces Positive Results from Phase 2b Clinical Trial in Tinea Pedis

DermBiont Announces Positive Results from Phase 2b Clinical Trial in Tinea Pedis

DermBiont's biotherapeutics discovery team leverages computational biology and a proprietary bioinformatics platform to identify clinically meaningful dysbiosis related to common skin diseases and mines a curated library of microbes to build a pipeline of products to treat identified dysbiosis across indications. ...

ByDermBiont, Inc.


NEC publishes design blueprints for SARS-CoV-2 vaccines using its Artificial Intelligence technology

NEC publishes design blueprints for SARS-CoV-2 vaccines using its Artificial Intelligence technology

Oslo, April 22, 2020 – NEC OncoImmunity AS today announced analysis results from efforts using AI prediction platforms to design blueprints for SARS-CoV-2 vaccines that can drive potent T-cell responses in the majority of the global population. ...

ByNEC OncoImmunity AS 


Agilent Technologies expands next-generation sequencing target-enrichment platform with SureCall Software upgrade

Agilent Technologies expands next-generation sequencing target-enrichment platform with SureCall Software upgrade

SureCall software enables clinical researchers to transform raw NGS data into insightful analyses without requiring advanced bioinformatics training or laboratory infrastructure. "In NGS clinical cancer research, analysis is the key," said Dr. ...

ByAgilent Technologies, Inc.


Agilent Technologies names expression analysis as certified service provider for target enrichment in next-generation sequencing

Agilent Technologies names expression analysis as certified service provider for target enrichment in next-generation sequencing

"We have added the SureSelect platform in response to significant client demand," said Steve McPhail, president and CEO of Expression Analysis. "Responding to client requirements has been a cornerstone to our success. This platform complements our current technologies and will allow us to meet client demands on many fronts." ...

ByAgilent Technologies, Inc.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT